Liver/Biliary Disorders News

In this exclusive video, David A. Greenwald, MD, FACG, from Mount Sinai Hospital and President of the American College of Gastroenterology, discusses the upcoming hybrid ACG Annual Scientific Meeting.

The Nash-FibroTest non-invasive panel successfully diagnosed the stage of fibrosis as well as graded nonalcoholic steatohepatitis and steatosis among patients with type 2 diabetes, according to a recent study.

About 25% of U.S. adults have nonalcoholic fatty liver disease, which is the most common chronic liver condition in the U.S., according to the American Liver Foundation.

This month’s cover story puts forth a call to action for our fellow physicians to be more aware of fatty liver disease risk. But this call needs to be about more than awareness. It must be a call for multidisciplinary coordinated screening and follow-up.

Among patients with nonalcoholic fatty liver disease, AXA1125 showed greater activity over 16 weeks compared with AXA1957 and placebo, according to a study published in The American Journal of Gastroenterology.

Among liver transplantation recipients, Black recipients vs. white and Hispanic recipients continue to have a survival disadvantage, according to a study in the American Journal of Transplantation.

Vivet Therapeutics announced it received FDA fast track designation for VTX-801, which is intended for treatment of Wilson disease.

Among a population with low consumption of red meat, those who consumed a high amount of red meat had a high chance for nonalcoholic fatty liver disease, according to a study published in the American Journal of Gastroenterology.

Healio Gastroenterology presents the following report on the top 10 peer-tested stories in July.

Patients with non-alcoholic fatty liver disease benefited from encouragement to complete a low-energy diet even if there were no adherence issues with intervention plans, according to results published in BMJ Open Gastroenterology.